EP Patent

EP2838518B1 — Method of treating acne

Assigned to Galderma SA · Expires 2018-02-21 · 8y expired

What this patent protects

Patent listed against Vibramycin.

Drugs covered by this patent

Vibramycin (doxycycline) · Generic (originally Pfizer)

Patent Metadata

Patent number: EP2838518B1
Jurisdiction: EP
Classification: —
Expires: 2018-02-21
Drug substance claim: No
Drug product claim: No
Assignee: Galderma SA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.